Mumbai: Pharma Major, NATCO Pharma on Friday said that its marketing partner Breckenridge Pharmaceutical, Inc., US has launched the 10mg strength of Everolimus Tablets (generic for Afinitor) in the US market.
The U.S. Food and Drug Administration previously granted final approval of this Abbreviated New Drug Application. According to industry sales data, the 10mg strength of Afinitor generated annual sales of USD392 million during the twelve months ending July 2021.
Breckenridge previously launched Everolimus tablets in 2.5mg, 5mg and 7.5mg strengths during the first quarter of 2021 in the US market.
UNI
NATCO marketing partner Breckenridge Pharmaceutical launches 10mg strength Everolimus Tablets in US is added by Agencies on View all posts by Agencies →
Subscribe THE MORN
